605116 奥锐特
未开盘 05-21 09:30:00
资讯
新帖
简况
北向资金5月13日净买入奥锐特2.63万股 连续3日增持
自选股智能写手 · 05-14
北向资金5月13日净买入奥锐特2.63万股 连续3日增持
量子通信概念盘中跳水，奥锐特跌0.36%
自选股智能写手 · 05-13
量子通信概念盘中跳水，奥锐特跌0.36%
北向资金5月8日净卖出奥锐特1.48万股 连续3日减持
自选股智能写手 · 05-09
北向资金5月8日净卖出奥锐特1.48万股 连续3日减持
AI制药新进展：谷歌推出新一代模型 产业链一览
腾讯自选股 · 05-09
AI制药新进展：谷歌推出新一代模型 产业链一览
奥锐特： 合成生物学是公司的六大研发平台之一，目前已应用于司美格鲁肽、瑞美吉泮、维贝格隆等产品
证券之星 · 05-08
奥锐特： 合成生物学是公司的六大研发平台之一，目前已应用于司美格鲁肽、瑞美吉泮、维贝格隆等产品
奥锐特：合成生物学已应用于司美格鲁肽、瑞美吉泮等产品
第一财经 · 05-08
奥锐特：合成生物学已应用于司美格鲁肽、瑞美吉泮等产品
奥锐特05月07日遭主力抛售1127万元 环比增加1810.17%
自选股智能写手 · 05-07
奥锐特05月07日遭主力抛售1127万元 环比增加1810.17%
北向资金4月30日净买入奥锐特17.58万股 连续3日增持
自选股智能写手 · 05-06
北向资金4月30日净买入奥锐特17.58万股 连续3日增持
奥锐特获中国银河买入评级，原料药业务稳健增长，地屈孕酮片开启制剂新篇章
金融界 · 05-02
奥锐特获中国银河买入评级，原料药业务稳健增长，地屈孕酮片开启制剂新篇章
奥锐特2023年营收净利双增，“原料药+制剂”一体化战略取得重大突破
览富财经网 · 04-29
奥锐特2023年营收净利双增，“原料药+制剂”一体化战略取得重大突破
量子计算概念盘中跳水，奥锐特跌0.97%
自选股智能写手 · 04-29
量子计算概念盘中跳水，奥锐特跌0.97%
奥锐特最新公告：2023年净利润同比增加37.19% 拟10派2.2元
证券之星 · 04-28
奥锐特最新公告：2023年净利润同比增加37.19% 拟10派2.2元
图解奥锐特一季报：第一季度单季净利润同比增79.14%
证券之星 · 04-28
图解奥锐特一季报：第一季度单季净利润同比增79.14%
奥锐特(605116.SH)发布一季度业绩，净利润8218.42万元 同比增加79.14%
智通财经 · 04-28
奥锐特(605116.SH)发布一季度业绩，净利润8218.42万元 同比增加79.14%
奥锐特(605116.SH)发布2023年度业绩，净利润2.89亿元 同比增加37.19%
智通财经 · 04-28
奥锐特(605116.SH)发布2023年度业绩，净利润2.89亿元 同比增加37.19%
奥锐特(605116)3月31日股东户数0.78万户，较上期增加1.14%
证券之星 · 04-28
奥锐特(605116)3月31日股东户数0.78万户，较上期增加1.14%
奥锐特最新公告：一季度净利润8218.42万元 同比增长79.14%
证券之星 · 04-28
奥锐特最新公告：一季度净利润8218.42万元 同比增长79.14%
奥锐特：2024年第一季度净利润约8218万元
每日经济新闻 · 04-28
奥锐特：2024年第一季度净利润约8218万元
图解奥锐特年报：第四季度单季净利润同比增131.47%
证券之星 · 04-28
图解奥锐特年报：第四季度单季净利润同比增131.47%
北向资金4月24日净买入奥锐特14.57万股 连续3日增持
自选股智能写手 · 04-25
北向资金4月24日净买入奥锐特14.57万股 连续3日增持
加载更多
公司概况
公司名称：
奥锐特药业股份有限公司
所属行业：
医药制造业
上市日期：
2020-09-21
主营业务：
奥锐特药业股份有限公司主营业务是特色原料药和医药中间体的研发、生产和销售。主要产品为呼吸系统类、心血管类、抗感染类和神经系统类药物，包括氟美松、丙酸氟替卡松、依普利酮、替诺福韦、普瑞巴林等原料药和中间体。公司已经通过了包括NMPA、FDA、WHO、BGV等监管机构的认证，目前已经有1个产品通过WHO的审计，4个产品取得欧盟CEP认证，3个产品取得了欧盟GMP证书，5个产品取得了出口欧盟的证明，11个产品已经提交了美国DMF文件，建立了独具竞争力的自主品牌，成为国内出口特色原料药较多的企业之一。
发行价格：
8.37
{"stockData":{"symbol":"605116","market":"SH","secType":"STK","nameCN":"奥锐特","latestPrice":23.59,"timestamp":1716253910000,"preClose":23.59,"halted":0,"volume":0,"delay":0,"floatShares":395000000,"shares":405999999,"eps":0.8019,"marketStatus":"未开盘","marketStatusCode":0,"change":0,"latestTime":"05-21 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.8019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716255000000},"adr":0,"adjPreClose":23.59,"symbolType":"stock","openAndCloseTimeList":[[1716255000000,1716262200000],[1716267600000,1716274800000]],"highLimit":25.95,"lowLimit":21.23,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406195000,"pbRate":4.66,"roa":"--","roe":"3.14%","epsLYR":0.71,"marketValue":9582000000,"floatMarketCap":9328000000,"peRate":29.417632,"changeRate":0,"turnoverRate":0,"status":2},"requestUrl":"/m/hq/s/605116","defaultTab":"news","newsList":[{"id":"2435352075","title":"北向资金5月13日净买入奥锐特2.63万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2435352075","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435352075?lang=zh_cn&edition=full","pubTime":"2024-05-14 09:30","pubTimestamp":1715650234,"startTime":"0","endTime":"0","summary":"5月13日, 北向资金增持奥锐特2.63万股，连续3日增持。截止当日收盘，沪股通共持有奥锐特83.56万股，占流通股0.21%。沪股通增持金额前五个股分别为恒瑞医药、江苏银行、中国建筑、山西汾酒、兆易创新。奥锐特近5个交易日下跌1.89%，沪股通累计增持5.99万股；近20个交易日上涨7.48%，沪股通累计增持24.37万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140934128b0493cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405140934128b0493cd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435393071","title":"量子通信概念盘中跳水，奥锐特跌0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435393071","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435393071?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:38","pubTimestamp":1715564339,"startTime":"0","endTime":"0","summary":"05月13日，量子通信概念盘中跳水，截至09点38分，量子通信概念整体指数下跌2.10%，报3025.310点。从个股上来看，该概念的成分股中，奥锐特跌0.36%，中国移动、科大讯飞跌幅居前。从资金上来看，截止发稿，量子通信概念主力净流入为-1.82亿，其中亨通光电受到资金热捧，主力净流入7571.93万；拉长时间线来看，该板块近20日主力资金净流入-99.79亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130938597a597630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405130938597a597630&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434087898","title":"北向资金5月8日净卖出奥锐特1.48万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2434087898","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434087898?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:30","pubTimestamp":1715218235,"startTime":"0","endTime":"0","summary":"5月8日，北向资金减持奥锐特1.48万股连续3日减持。截止当日收盘，沪股通共持有奥锐特74.22万股，占流通股0.18%。沪股通减持金额前五个股分别为国电南瑞、寒武纪-U、方正证券、药明康德、隆基绿能。奥锐特近5个交易日上涨2.03%，沪股通累计增持12.37万股；近20个交易日上涨14.07%，沪股通累计增持11.99万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050909342587e25ecd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050909342587e25ecd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434611086","title":"AI制药新进展：谷歌推出新一代模型 产业链一览","url":"https://stock-news.laohu8.com/highlight/detail?id=2434611086","media":"腾讯自选股","top":-1,"share":"https://www.laohu8.com/m/news/2434611086?lang=zh_cn&edition=full","pubTime":"2024-05-09 08:14","pubTimestamp":1715213647,"startTime":"0","endTime":"0","summary":"美东时间周三，谷歌DeepMind发布了新一代预测蛋白质结构的AlphaFold 3模型，能够帮助科学家更精确地针对疾病机制，从而开发出更有效的治疗药物。据太平洋证券医药，AI制药内涵丰富，主要包括：数字生物学、计算机药物发现、实验室自动化、AI 辅助临床试验等。整体而言AI技术在制药领域的应用价值主要体现在缩短试验周期、节省成本、促进新事物发现、提升试验成功概率等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509075702861ebda0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433712745","title":"奥锐特：\n合成生物学是公司的六大研发平台之一，目前已应用于司美格鲁肽、瑞美吉泮、维贝格隆等产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2433712745","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2433712745?lang=zh_cn&edition=full","pubTime":"2024-05-08 17:01","pubTimestamp":1715158892,"startTime":"0","endTime":"0","summary":"证券之星消息，奥锐特(605116)05月08日在投资者关系平台上答复投资者关心的问题。投资者：尊敬的董秘，您好，请问贵公司在合成生物方面有哪些技术布局，谢谢。奥锐特董秘：尊敬的投资者您好！合成生物学是公司的六大研发平台之一，目前已应用于司美格鲁肽、瑞美吉泮、维贝格隆等产品。感谢关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800029666.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2433715206","title":"奥锐特：合成生物学已应用于司美格鲁肽、瑞美吉泮等产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2433715206","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2433715206?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:38","pubTimestamp":1715153892,"startTime":"0","endTime":"0","summary":"奥锐特在互动平台表示，合成生物学是公司的六大研发平台之一，目前已应用于司美格鲁肽、瑞美吉泮、维贝格隆等产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508153813792676a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508153813792676a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433242513","title":"奥锐特05月07日遭主力抛售1127万元 环比增加1810.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433242513","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433242513?lang=zh_cn&edition=full","pubTime":"2024-05-07 15:19","pubTimestamp":1715066364,"startTime":"0","endTime":"0","summary":"05月07日, 奥锐特股价涨0.76%，报收25.08元，成交金额7057万元，换手率0.71%，振幅1.57%，量比0.93。奥锐特今日主力资金净流出1127万元，上一交易日主力净流出59万元，今日环比增加1810.17%。该股近5个交易日上涨1.87%，主力资金累计净流出3770万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出5601万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071537118ae41be0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071537118ae41be0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433469285","title":"北向资金4月30日净买入奥锐特17.58万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2433469285","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433469285?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:30","pubTimestamp":1714959031,"startTime":"0","endTime":"0","summary":"4月30日, 北向资金增持奥锐特17.58万股，连续3日增持。截止当日收盘，沪股通共持有奥锐特84.47万股，占流通股0.21%。沪股通增持金额前五个股分别为江苏银行、中远海控、招商银行、中国石油、赤峰黄金。奥锐特近5个交易日上涨3.65%，沪股通累计增持20.21万股；近20个交易日上涨10.75%，沪股通累计增持18.23万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050609352187d64594&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050609352187d64594&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432696423","title":"奥锐特获中国银河买入评级，原料药业务稳健增长，地屈孕酮片开启制剂新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=2432696423","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432696423?lang=zh_cn&edition=full","pubTime":"2024-05-02 09:44","pubTimestamp":1714614254,"startTime":"0","endTime":"0","summary":"5月2日，奥锐特获中国银河买入评级，近一个月奥锐特获得2份研报关注。研报预计公司2024-2026年收入分别为16.24、20.20、24.25亿元，同比增长28.62%、24.42%、20.01%，归母净利润为3.94、5.15、6.59亿元，同比增长36.2%、30.65%、27.92%。研报认为，公司特色高壁垒原料药及中间体品种商业化有望支撑利润稳健增长，公司在小核酸&多肽领域的技术&产品布局有望打开中长期增长空间。风险提示：市场竞争的风险，市场推广不及预期的风险，新品研发不及预期的风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050209441487c952ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050209441487c952ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431207077","title":"奥锐特2023年营收净利双增，“原料药+制剂”一体化战略取得重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2431207077","media":"览富财经网","top":-1,"share":"https://www.laohu8.com/m/news/2431207077?lang=zh_cn&edition=full","pubTime":"2024-04-29 14:00","pubTimestamp":1714370401,"startTime":"0","endTime":"0","summary":"4月28日晚，奥锐特发布了2023年年度报告，报告期内，公司实现营业收入 12.63 亿元，较上年同期增长 25.24%；实现归母净利润 2.89 亿元，较上年同期增长 37.19%；实现扣非净利润为 2.61 亿元，较上年同期增长 26.38%。同时，2023年6月公司获得国家药监局核准签发的地屈孕酮片《药品注册证书》，这是中国首个上市的地屈孕酮片仿制药，也是公司首个获批的制剂产品，标志着公司“原料药+制剂”一体化战略取得重大突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042914143187bdaff3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042914143187bdaff3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431504425","title":"量子计算概念盘中跳水，奥锐特跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431504425","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431504425?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:44","pubTimestamp":1714355052,"startTime":"0","endTime":"0","summary":"04月29日，量子计算概念盘中跳水，截至09点44分，量子计算概念整体指数下跌0.57%，报1017.570点。从个股上来看，该概念的成分股中，奥锐特跌0.97%，跌幅居前。从资金上来看，截止发稿，量子计算概念主力净流入为-4.24亿，其中博实股份受到资金热捧，主力净流入2246.93万；拉长时间线来看，该板块近20日主力资金净流入0.00万。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290944127a56df00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404290944127a56df00&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430304059","title":"奥锐特最新公告：2023年净利润同比增加37.19% 拟10派2.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430304059","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430304059?lang=zh_cn&edition=full","pubTime":"2024-04-28 20:01","pubTimestamp":1714305693,"startTime":"0","endTime":"0","summary":"奥锐特发布2023年度业绩报告，报告期内公司实现营业收入12.63亿元，同比增加25.24%;归属于上市公司股东的净利润2.89亿元，同比增加37.19%，公司拟向全体股东每10股派发现金红利人民币2.20元(含税)。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800008764.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430031871","title":"图解奥锐特一季报：第一季度单季净利润同比增79.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430031871","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430031871?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:35","pubTimestamp":1714296908,"startTime":"0","endTime":"0","summary":"证券之星消息，奥锐特2024年一季报显示，公司主营收入3.36亿元，同比上升11.08%；归母净利润8218.42万元，同比上升79.14%；扣非净利润8216.78万元，同比上升87.43%；负债率23.44%，投资收益47.68万元，财务费用-1164.24万元，毛利率53.68%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800005978.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430503693","title":"奥锐特(605116.SH)发布一季度业绩，净利润8218.42万元 同比增加79.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430503693","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430503693?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:14","pubTimestamp":1714295645,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥锐特(605116.SH)发布2024年一季度报告，报告期内公司实现营业收入3.36亿元，同比增加11.08%;归属于上市公司股东的净利润8218.42万元，同比增加79.14%;归属于上市公司股东的扣除非经常性损益的净利润8216.78万元，同比增加87.43%;基本每股收益0.2元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113349.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430903653","title":"奥锐特(605116.SH)发布2023年度业绩，净利润2.89亿元 同比增加37.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430903653","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430903653?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:11","pubTimestamp":1714295497,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥锐特(605116.SH)发布2023年度业绩报告，报告期内公司实现营业收入12.63亿元，同比增加25.24%;归属于上市公司股东的净利润2.89亿元，同比增加37.19%;归属于上市公司股东的扣除非经常性损益的净利润2.61亿元，同比增加26.38%;基本每股收益0.71元，公司拟向全体股东每10股派发现金红利人民币2.20元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1113343.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430039422","title":"奥锐特(605116)3月31日股东户数0.78万户，较上期增加1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430039422","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430039422?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:06","pubTimestamp":1714295179,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥锐特披露，截至2024年3月31日公司股东户数为7801.0户，较12月31日增加88.0户，增幅为1.14%。在化学制药行业个股中，奥锐特股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.3万户。从股价来看，2023年12月31日至2024年3月31日，奥锐特区间跌幅为14.64%，在此期间股东户数增加88.0户，增幅为1.14%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042817143287ba3fe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042817143287ba3fe4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430103685","title":"奥锐特最新公告：一季度净利润8218.42万元 同比增长79.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430103685","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430103685?lang=zh_cn&edition=full","pubTime":"2024-04-28 17:00","pubTimestamp":1714294855,"startTime":"0","endTime":"0","summary":"奥锐特发布2024年第一季度报告，实现营业收入3.36亿元，同比增长11.08%；归属于上市公司股东的净利润8218.42万元，同比增长79.14%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800004362.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430221035","title":"奥锐特：2024年第一季度净利润约8218万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430221035","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2430221035?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:44","pubTimestamp":1714293854,"startTime":"0","endTime":"0","summary":"奥锐特（SH 605116，收盘价：24.64元）4月28日晚间发布一季度业绩公告称，2024年第一季度营收约3.36亿元，同比增加11.08%；归属于上市公司股东的净利润约8218万元，同比增加79.14%；基本每股收益0.2元，同比增加81.82%。截至发稿，奥锐特市值为100亿元。文章来源：每日经济新闻原标题：奥锐特：2024年第一季度净利润约8218万元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281649288b5d3fd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281649288b5d3fd2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430033552","title":"图解奥锐特年报：第四季度单季净利润同比增131.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430033552","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430033552?lang=zh_cn&edition=full","pubTime":"2024-04-28 16:38","pubTimestamp":1714293513,"startTime":"0","endTime":"0","summary":"证券之星消息，奥锐特2023年年报显示，公司主营收入12.63亿元，同比上升25.24%；归母净利润2.89亿元，同比上升37.19%；扣非净利润2.61亿元，同比上升26.38%；其中2023年第四季度，公司单季度主营收入3.4亿元，同比上升42.19%；单季度归母净利润5687.27万元，同比上升131.47%；单季度扣非净利润6656.0万元，同比上升175.13%；负债率23.58%，投资收益3172.26万元，财务费用-1646.55万元，毛利率55.92%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042800003935.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430140644","title":"北向资金4月24日净买入奥锐特14.57万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430140644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430140644?lang=zh_cn&edition=full","pubTime":"2024-04-25 09:30","pubTimestamp":1714008630,"startTime":"0","endTime":"0","summary":"4月24日, 北向资金增持奥锐特14.57万股，连续3日增持。截止当日收盘，沪股通共持有奥锐特78.83万股，占流通股0.19%。沪股通增持金额前五个股分别为中国平安、海尔智家、农业银行、招商银行、万华化学。奥锐特近5个交易日上涨5.86%，沪股通累计增持25.05万股；近20个交易日上涨7.75%，沪股通累计减持3.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404250935348b50ead7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404250935348b50ead7&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-09-21","address":"浙江省台州市天台县八都工业园区","stockEarnings":[{"period":"1week","weight":-0.034},{"period":"1month","weight":0.0369},{"period":"3month","weight":0.0392},{"period":"6month","weight":-0.0774},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":-0.0864}],"companyName":"奥锐特药业股份有限公司","boardCode":"AI0027","perCapita":"50690股","boardName":"医药制造业","registeredCapital":"40619万元","compareEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.085},{"period":"6month","weight":0.0419},{"period":"1year","weight":-0.0342},{"period":"ytd","weight":0.066}],"survey":" 奥锐特药业股份有限公司主营业务是特色原料药和医药中间体的研发、生产和销售。主要产品为呼吸系统类、心血管类、抗感染类和神经系统类药物，包括氟美松、丙酸氟替卡松、依普利酮、替诺福韦、普瑞巴林等原料药和中间体。公司已经通过了包括NMPA、FDA、WHO、BGV等监管机构的认证，目前已经有1个产品通过WHO的审计，4个产品取得欧盟CEP认证，3个产品取得了欧盟GMP证书，5个产品取得了出口欧盟的证明，11个产品已经提交了美国DMF文件，建立了独具竞争力的自主品牌，成为国内出口特色原料药较多的企业之一。","serverTime":1716253934651,"listedPrice":8.37,"stockholders":"7801人(较上一季度增加1.14%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥锐特,605116,奥锐特股票,奥锐特股票老虎,奥锐特股票老虎国际,奥锐特行情,奥锐特股票行情,奥锐特股价,奥锐特股市,奥锐特股票价格,奥锐特股票交易,奥锐特股票购买,奥锐特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}